{"id":3713,"date":"2020-08-26T09:16:52","date_gmt":"2020-08-26T09:16:52","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/amsbio-introduces-stemfit-for-differentiation-for-human-ips-and-es-cells\/"},"modified":"2021-01-08T11:20:29","modified_gmt":"2021-01-08T11:20:29","slug":"amsbio-introduces-stemfit-for-differentiation-for-human-ips-and-es-cells","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/amsbio-introduces-stemfit-for-differentiation-for-human-ips-and-es-cells\/","title":{"rendered":"AMSBIO introduces StemFit for Differentiation for human iPS and ES cells"},"content":{"rendered":"

AMSBIO has introduced StemFit for Differentiation \u2013 a new chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.
\nThe unique chemically defined composition of StemFit for Differentiation minimizes lot-to-lot variation, enabling highly consistent cell differentiation. Free of animal- and human-derived components, StemFit for Differentiation can be used to eliminate the risk of immunogenic contamination.
\nApplications proven to benefit from StemFit for Differentiation include: lineage-specific (endodermal, mesodermal and ectodermal) differentiation where this new product is used to replace serum-free supplements, as well as spontaneous differentiation of hiPSCs to organoids via embryoid body formation.
\nUsed in combination with StemFit Basic feeder-free medium with iMatrix-511 laminin as extracellular matrix, StemFit for Differentiation enables researchers to undertake clinical applications involving both expansion and differentiation of human Pluripotent Stem Cell-derived cells and tissues.
\nSupplied as a 5X concentrate, StemFit for Differentiation has been formulated for use with basal cell culture medium (e.g. DMEM, RPMI 1640, DMEM\/F12 etc.) and a variety of different induction factors or cytokines (including Activin A and bFGF from AMSBIO).<\/p>\n